Nuvation Bio DSO Ratio 2011-2026 | NUVB

Annual DSO Ratio Nuvation Bio

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
83.6	295	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
295	83.6	189

Quarterly DSO Ratio Nuvation Bio

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
38.3	29.3	194	-	14.4	3.72	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
194	3.72	56

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
AbCellera Biologics ABCL	173	$ 3.44	-4.32 %	$ 1.03 B	Canada
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
ADMA Biologics ADMA	74.6	$ 15.36	-2.17 %	$ 3.66 B	USA
Cellectis S.A. CLLS	94.5	$ 3.53	-3.54 %	$ 116 M	France
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Apellis Pharmaceuticals APLS	115	$ 20.28	0.65 %	$ 2.56 B	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Nymox Pharmaceutical Corporation NYMX	12.5	-	-19.68 %	$ 18.4 M	Canada
Aptorum Group Limited APM	20.6	$ 0.79	-1.15 %	$ 4.31 M	China
China SXT Pharmaceuticals SXTC	318	$ 2.01	-1.36 %	$ 2.86 M	China
Galmed Pharmaceuticals Ltd. GLMD	33.4	$ 0.67	7.08 %	$ 624 K	Israel
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Anika Therapeutics ANIK	77.3	$ 14.05	-1.44 %	$ 206 M	USA
ANI Pharmaceuticals ANIP	114	$ 74.36	-1.64 %	$ 1.44 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Athersys ATHX	22.6	-	3.77 %	$ 22.4 M	USA
AVEO Pharmaceuticals AVEO	47.5	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	105	$ 162.43	0.6 %	$ 8.08 B	USA
BioCryst Pharmaceuticals BCRX	55.1	$ 8.49	-0.18 %	$ 1.75 B	USA
BridgeBio Pharma BBIO	52.4	$ 65.66	-0.78 %	$ 12.6 B	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	103	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
BioMarin Pharmaceutical BMRN	88.9	$ 61.3	1.21 %	$ 11.8 B	USA
CymaBay Therapeutics CBAY	182	-	-	$ 3.45 B	USA